Tuberculosis and Impact of COVID-19 on Spread of Epidemics in Kazakhstan.

Publication date: Jun 04, 2025

This study examines the epidemiological situation of tuberculosis (TB) in the regions of the Republic of Kazakhstan over the past seven years (2018-2024), which cover the before-, during- and after-COVID-19 periods, with a focus on the risks of its emergence and spread. The analysis revealed that while TB incidence is declining, mortality remains high in the before- and during-COVID-19 periods, indicating a general decline in population health. The concentration of TB incidence in relation to geographic location was mainly in the northern, western and southern regions. Before COVID-19, TB incidence reached 48. 2 cases and mortality reached a maximum of 2. 4 cases per 100,000 people. In 2024, the incidence and mortality of tuberculosis significantly decreased to 33. 5 (30. 5%) and 1. 0 (58. 3%), respectively, reflecting an improvement in health indicators in the post-pandemic period. In the after-COVID-19 period, in regions with high unemployment, the incidence was higher than in the before- and during-COVID-19 periods. Nevertheless, it is important that the trend in tuberculosis incidence shows positive improvement after the COVID-19 period. In addition, a comparative analysis of tuberculosis incidence trends in different age groups and social factor groups shows that the adult population remains the most vulnerable category among the general population. The above-listed factors, as well as our analysis of tuberculosis incidence, shows that TB incidence does not always correlate with the level of vaccination in different regions of Kazakhstan, indicating a multifactorial influence on the tuberculosis epidemic.

Open Access PDF

Concepts Keywords
High Adolescent
Kazakhstan Adult
Tuberculosis Aged
Vaccination Child
Child, Preschool
COVID-19
Epidemics
epidemiological situation
Female
Humans
Incidence
Infant
infectious diseases
Kazakhstan
Male
Middle Aged
Mycobacterium tuberculosis
SARS-CoV-2
TB incidence
TB mortality
Tuberculosis
tuberculosis
unemployment
vaccination
Young Adult

Semantics

Type Source Name
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH COVID-19
disease MESH unemployment
drug DRUGBANK Coenzyme M
disease MESH infectious diseases
disease IDO bacteria
disease MESH infection
disease IDO pathogen
disease MESH chest pain
disease MESH death
disease MESH AIDS
disease IDO antibiotic resistance
disease IDO host
disease MESH alcohol dependence
disease MESH malnutrition
disease IDO country
drug DRUGBANK Aspartame
drug DRUGBANK Polyethylene glycol
disease MESH morbidity

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *